Lithium-induced Nephrogenic Diabetes Insipidus with Efficacy of Desmopressin in Combination with Thiazide Diuretics and Non-steroidal Anti-inflammatory Drugs: A Case Report with a Review of the Literature

Intern Med. 2023 Sep 29. doi: 10.2169/internalmedicine.2437-23. Online ahead of print.ABSTRACTNephrogenic diabetes insipidus (NDI) is characterized by excessive urination and an inability to concentrate urine. Lithium is the most common cause of acquired NDI. Treatment typically involves thiazide diuretics and nonsteroidal anti-inflammatory drugs (NSAIDs). However, the efficacy of desmopressin in NDI remains unclear. We herein report a case of lithium-induced NDI in a 71-year-old woman with lithium-induced NDI. Thiazide diuretics and NSAIDs reduced the urine output by approximately 40% compared to pretreatment, while the addition of desmopressin reduced it by approximately 70%. This case suggests that desmopressin can be a viable treatment option for lithium-induced NDI.PMID:37779064 | DOI:10.2169/internalmedicine.2437-23

Source: Internal Medicine - October 1, 2023 Category: Internal Medicine Authors: Takanobu Jinnouchi Munehiro Yoshimoto Kei Ogino Tomoatsu Oji Michio Hayashi Source Type: research